A randomized, multicenter study of G-CSF starting on day +1 vs day +5 after autologous peripheral blood progenitor cell transplantationDE AZEVEDO, A. M; NUCCI, M; MAIOLINO, A et al.Bone marrow transplantation (Basingstoke). 2002, Vol 29, Num 9, pp 745-751, issn 0268-3369Article

Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteriaMAIOLINO, A; BIASOLI, I; LIMA, J et al.Bone marrow transplantation (Basingstoke). 2003, Vol 31, Num 5, pp 393-397, issn 0268-3369, 5 p.Article

Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantationNUCCI, M; ANDRADE, F; VIGORITO, A et al.Transplant infectious disease (Print). 2003, Vol 5, Num 4, pp 167-173, issn 1398-2273, 7 p.Article

Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patientsNUCCI, M; BIASOLI, I; BRAGGIO, S et al.Oncology reports. 1998, Vol 5, Num 5, pp 1205-1209, issn 1021-335XArticle

Cyclosporin A and chronic graft versus host diseaseBACIGALUPO, A; MAIOLINO, A; VAN LINT, M. T et al.Bone marrow transplantation (Basingstoke). 1990, Vol 6, Num 5, pp 341-344, issn 0268-3369, 4 p.Article

Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipientsOLIVEIRA, A. L; DE SOUZA, M; ZANICHELLI, M. A et al.Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 12, pp 775-781, issn 0268-3369, 7 p.Article